Cantel Medical (CMD) Tops Q4 EPS by 1c
Cantel Medical (NYSE: CMD) reported Q4 EPS of $0.54, $0.01 better than the analyst estimate of $0.53. Revenue for the quarter came in at $205.5 million versus the consensus estimate of $200.32 million.
For earnings history and earnings-related data on Cantel Medical (CMD) click here.